首页> 外文OA文献 >Efficacy and safety of saxagliptin in combination with insulin in Japanese patients with type 2 diabetes mellitus: a 16-week double-blind randomized controlled trial with a 36-week open-label extension

【2h】

Efficacy and safety of saxagliptin in combination with insulin in Japanese patients with type 2 diabetes mellitus: a 16-week double-blind randomized controlled trial with a 36-week open-label extension

机译：Saxagliptin与日本患者2型糖尿病患者胰岛素组合的疗效和安全性：一个16周的双盲随机对照试验，36周的开放标签延伸

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Takashi Kadowaki; Satsuki Muto; Yoshiumi Ouchi; Ryutaro Shimazaki; Yutaka Seino;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of saxagliptin in combination with insulin in Japanese patients with type 2 diabetes mellitus: a 16-week double-blind randomized controlled trial with a 36-week open-label extension [J] . Kadowaki Takashi, Muto Satsuki, Ouchi Yoshiumi, Expert opinion on pharmacotherapy . 2017,第13a18期

机译：Saxagliptin与日本患者2型糖尿病患者胰岛素组合的疗效和安全性：一个16周的双盲随机对照试验，36周的开放标签延伸
2. Efficacy and safety of teneligliptin add-on to insulin monotherapy in Japanese patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled trial with an open-label period [J] . Kadowaki Takashi, Kondo Kazuoki, Sasaki Noriyuki, Expert opinion on pharmacotherapy . 2017,第13a18期

机译：Teneligliptin附加加载作用于2型糖尿病患者胰岛素单疗法的疗效和安全性：16周，随机，双盲，安慰剂对照试验，开放标签
3. Efficacy and safety of tofogliflozin in Japanese patients with type 2 diabetes mellitus with inadequate glycaemic control on insulin therapy (J-STEP/INS): Results of a 16-week randomized, double-blind, placebo-controlled multicentre trial [J] . Terauchi Yasuo, Tamura Masahiro, Senda Masayuki, Diabetes, obesity & metabolism . 2017,第10期

机译：Tofogliflozin在日本型糖尿病患者中的疗效和安全性，胰岛素治疗血糖控制不足（J-STEP / INS）：16周随机化，双盲，安慰剂控制的多期式试验结果
4. A series of open-label studies comparing various formulations of orally administeredinsulin (Oralin) in patients with Type -1 Diabetes Mellitus (DM) [C] . Jaime Guevara-Aguirre, Marco Guevara, Jeannette Saavedra Annual meeting exposition of the Controlled Release Society . 2005

机译：一系列开放标签研究比较了-1型糖尿病（DM）患者口服胰岛素（Oralin）的各种配方
5. A 4-month randomized controlled clinical trial of adjuvant Exenatide or Pramlintide versus insulin alone in pediatric type 1 diabetes mellitus: Effect on glycemic control. [D] . Withycombe, Sarah Elizabeth. 2010

机译：儿科1型糖尿病患者中艾塞那肽或普兰林肽与单独使用胰岛素的4个月随机对照临床试验：对血糖控制的影响。
6. Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a 36-week open-label extension of a 16-week randomized placebo-controlled double-blind study [O] . Hisamitsu Ishihara, Susumu Yamaguchi, Ikko Nakao, 2019

机译：依普列净作为日本2型糖尿病患者（IOLITE）胰岛素的附加疗法的有效性和安全性：一项为期16周随机安慰剂对照双盲研究的36周开放标签研究
7. Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a 36-week, open-label extension of a 16-week, randomized, placebo-controlled, double-blind study [O] . Hisamitsu Ishihara, Susumu Yamaguchi, Ikko Nakao, 2018

机译：IPragliflozin作为胰岛素的胰岛素患者的胰岛素的疗效和安全性患者（Iolite）：36周，开放式标签延伸16周，随机，安慰剂控制，双盲研究

Efficacy and safety of saxagliptin in combination with insulin in Japanese patients with type 2 diabetes mellitus: a 16-week double-blind randomized controlled trial with a 36-week open-label extension

著录项

引文网络

相似文献

相关主题

期刊订阅